Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion
Authors:
Open Access
- 2 August 2022
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (32)
Abstract
Epstein-Barr virus (EBV) infects more than 90% of the world’s adult population and accounts for a significant cancer burden of epithelial and B cell origins. Glycoprotein B (gB) is the primary fusogen essential for EBV entry into host cells. Here, we isolated two EBV gB-specific neutralizing antibodies, 3A3 and 3A5; both effectively neutralized the dual-tropic EBV infection of B and epithelial cells. In humanized mice, both antibodies showed effective protection from EBV-induced lymphoproliferative disorders. Cryoelectron microscopy analyses identified that 3A3 and 3A5 bind to nonoverlapping sites on domains D-II and D-IV, respectively. Structure-based mutagenesis revealed that 3A3 and 3A5 inhibit membrane fusion through different mechanisms involving the interference with gB-cell interaction and gB activation. Importantly, the 3A3 and 3A5 epitopes are major targets of protective gB-specific neutralizing antibodies elicited by natural EBV infection in humans, providing potential targets for antiviral therapies and vaccines.Keywords
Funding Information
- National Natural Science Foundation of China (81872228)
- National Natural Science Foundation of China (82073756)
- National Natural Science Foundation of China (82030046)
This publication has 47 references indexed in Scilit:
- Epstein-Barr Virus: An Important Vaccine Target for Cancer PreventionScience Translational Medicine, 2011
- Bimolecular Complementation Defines Functional Regions of Herpes Simplex Virus gB That Are Involved with gH/gL as a Necessary Step Leading to Cell FusionJournal of Virology, 2010
- Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesvirusesProceedings of the National Academy of Sciences, 2009
- Binding of Herpes Simplex Virus Glycoprotein B (gB) to Paired Immunoglobulin-Like Type 2 Receptor α Depends on Specific Sialylated O - Linked Glycans on gBJournal of Virology, 2009
- Fusion of epithelial cells by Epstein–Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins αvβ6 or αvβ8Proceedings of the National Academy of Sciences, 2009
- Functional Analysis of Glycoprotein L (gL) from Rhesus Lymphocryptovirus in Epstein-Barr Virus-Mediated Cell Fusion Indicates a Direct Role of gL in gB-Induced Membrane FusionJournal of Virology, 2009
- Priming of protective T cell responses against virus-induced tumors in mice with human immune system componentsJournal of Experimental Medicine, 2009
- Analysis of Epstein-Barr Virus Glycoprotein B Functional Domains via Linker Insertion MutagenesisJournal of Virology, 2009
- PILRα Is a Herpes Simplex Virus-1 Entry Coreceptor That Associates with Glycoprotein BCell, 2008
- Random linker-insertion mutagenesis to identify functional domains of herpes simplex virus type 1 glycoprotein BProceedings of the National Academy of Sciences, 2007